Pharmaceuticals

United States Inhalers for Chronic Obstructive Pulmonary Disorder Market Report 2017

  • QYR907476
  • 120 Pages
  • February 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Inhalers for Chronic Obstructive Pulmonary Disorder

Revenue, means the sales value of Inhalers for Chronic Obstructive Pulmonary Disorder

This report studies sales (consumption) of Inhalers for Chronic Obstructive Pulmonary Disorder in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

AstraZeneca

Boehringer Ingelheim

GSK

Novartis

Teva Pharmaceuticals

Ache Laboratorios Farmaceuticos

Almirall

Aquinox Pharmaceuticals

Ario Pharma

Asmacure

Astellas Pharma

BioMarck Pharmaceuticals

Others

Market Segment by States, covering

California

Texas

New York

Florida

Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Metered-Dose Inhalers (MDI's)

Dry Powder Inhalers (DPI's)

Soft Mist Inhalers (SMI's)

Split by applications, this report focuses on sales, market share and growth rate of Inhalers for Chronic Obstructive Pulmonary Disorder in each application, can be divided into

GOLD 1? FEV1 ? 80%

GOLD 2? 50% ? FEV1 < 80%

GOLD 3? 30% ? FEV1 < 50%

GOLD 4? FEV1 < 30%

Table of Contents

United States Inhalers for Chronic Obstructive Pulmonary Disorder Market Report 2017

1 Inhalers for Chronic Obstructive Pulmonary Disorder Overview

1.1 Product Overview and Scope of Inhalers for Chronic Obstructive Pulmonary Disorder

1.2 Classification of Inhalers for Chronic Obstructive Pulmonary Disorder

1.2.1 Metered-Dose Inhalers (MDI's)

1.2.2 Dry Powder Inhalers (DPI's)

1.2.3 Soft Mist Inhalers (SMI's)

1.3 Application of Inhalers for Chronic Obstructive Pulmonary Disorder

1.3.1 GOLD 1? FEV1 ? 80%

1.3.2 GOLD 2? 50% ? FEV1 < 80%

1.3.3 GOLD 3? 30% ? FEV1 < 50%

1.3.4 GOLD 4? FEV1 < 30%

1.4 United States Market Size Sales (Volume) and Revenue (Value) of Inhalers for Chronic Obstructive Pulmonary Disorder (2012-2022)

1.4.1 United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2022)

1.4.2 United States Inhalers for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2022)

2 United States Inhalers for Chronic Obstructive Pulmonary Disorder Competition by Manufacturers

2.1 United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Inhalers for Chronic Obstructive Pulmonary Disorder Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Inhalers for Chronic Obstructive Pulmonary Disorder Average Price by Manufactures (2015 and 2016)

2.4 Inhalers for Chronic Obstructive Pulmonary Disorder Market Competitive Situation and Trends

2.4.1 Inhalers for Chronic Obstructive Pulmonary Disorder Market Concentration Rate

2.4.2 Inhalers for Chronic Obstructive Pulmonary Disorder Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales (Volume) and Revenue (Value) by States (2012-2017)

3.1 United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Market Share by States (2012-2017)

3.2 United States Inhalers for Chronic Obstructive Pulmonary Disorder Revenue and Market Share by States (2012-2017)

3.3 United States Inhalers for Chronic Obstructive Pulmonary Disorder Price by States (2012-2017)

4 United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales (Volume) and Revenue (Value) by Type (2012-2017)

4.1 United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Type (2012-2017)

4.2 United States Inhalers for Chronic Obstructive Pulmonary Disorder Revenue and Market Share by Type (2012-2017)

4.3 United States Inhalers for Chronic Obstructive Pulmonary Disorder Price by Type (2012-2017)

4.4 United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales Growth Rate by Type (2012-2017)

5 United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales (Volume) by Application (2012-2017)

5.1 United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Market Share by Application (2012-2017)

5.2 United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Inhalers for Chronic Obstructive Pulmonary Disorder Manufacturers Profiles/Analysis

6.1 AstraZeneca

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Inhalers for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification

6.1.2.1 Metered-Dose Inhalers (MDI's)

6.1.2.2 Dry Powder Inhalers (DPI's)

6.1.3 AstraZeneca Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Boehringer Ingelheim

6.2.2 Inhalers for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification

6.2.2.1 Metered-Dose Inhalers (MDI's)

6.2.2.2 Dry Powder Inhalers (DPI's)

6.2.3 Boehringer Ingelheim Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 GSK

6.3.2 Inhalers for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification

6.3.2.1 Metered-Dose Inhalers (MDI's)

6.3.2.2 Dry Powder Inhalers (DPI's)

6.3.3 GSK Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Novartis

6.4.2 Inhalers for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification

6.4.2.1 Metered-Dose Inhalers (MDI's)

6.4.2.2 Dry Powder Inhalers (DPI's)

6.4.3 Novartis Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Teva Pharmaceuticals

6.5.2 Inhalers for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification

6.5.2.1 Metered-Dose Inhalers (MDI's)

6.5.2.2 Dry Powder Inhalers (DPI's)

6.5.3 Teva Pharmaceuticals Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Ache Laboratorios Farmaceuticos

6.6.2 Inhalers for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification

6.6.2.1 Metered-Dose Inhalers (MDI's)

6.6.2.2 Dry Powder Inhalers (DPI's)

6.6.3 Ache Laboratorios Farmaceuticos Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Almirall

6.7.2 Inhalers for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification

6.7.2.1 Metered-Dose Inhalers (MDI's)

6.7.2.2 Dry Powder Inhalers (DPI's)

6.7.3 Almirall Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Aquinox Pharmaceuticals

6.8.2 Inhalers for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification

6.8.2.1 Metered-Dose Inhalers (MDI's)

6.8.2.2 Dry Powder Inhalers (DPI's)

6.8.3 Aquinox Pharmaceuticals Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Ario Pharma

6.9.2 Inhalers for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification

6.9.2.1 Metered-Dose Inhalers (MDI's)

6.9.2.2 Dry Powder Inhalers (DPI's)

6.9.3 Ario Pharma Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Asmacure

6.10.2 Inhalers for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification

6.10.2.1 Metered-Dose Inhalers (MDI's)

6.10.2.2 Dry Powder Inhalers (DPI's)

6.10.3 Asmacure Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

6.11 Astellas Pharma

6.12 BioMarck Pharmaceuticals

6.13 Others

7 Inhalers for Chronic Obstructive Pulmonary Disorder Manufacturing Cost Analysis

7.1 Inhalers for Chronic Obstructive Pulmonary Disorder Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Inhalers for Chronic Obstructive Pulmonary Disorder

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Inhalers for Chronic Obstructive Pulmonary Disorder Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Inhalers for Chronic Obstructive Pulmonary Disorder Major Manufacturers in 2015

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Inhalers for Chronic Obstructive Pulmonary Disorder Market Forecast (2017-2022)

11.1 United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue Forecast (2017-2022)

11.2 United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales Forecast by Type (2017-2022)

11.3 United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales Forecast by Application (2017-2022)

11.4 Inhalers for Chronic Obstructive Pulmonary Disorder Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix

Methodology

Analyst Introduction

Data Source

List of Tables and Figures

Figure Picture of Inhalers for Chronic Obstructive Pulmonary Disorder

Table Classification of Inhalers for Chronic Obstructive Pulmonary Disorder

Figure United States Sales Market Share of Inhalers for Chronic Obstructive Pulmonary Disorder by Type in 2015

Figure Metered-Dose Inhalers (MDI's) Picture

Figure Dry Powder Inhalers (DPI's) Picture

Figure Soft Mist Inhalers (SMI's) Picture

Table Application of Inhalers for Chronic Obstructive Pulmonary Disorder

Figure United States Sales Market Share of Inhalers for Chronic Obstructive Pulmonary Disorder by Application in 2015

Figure GOLD 1? FEV1 ? 80% Examples

Figure GOLD 2? 50% ? FEV1 < 80% Examples

Figure GOLD 3? 30% ? FEV1 < 50% Examples

Figure GOLD 4? FEV1 < 30% Examples

Figure United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales and Growth Rate (2012-2022)

Figure United States Inhalers for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate (2012-2022)

Table United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales of Key Manufacturers (2015 and 2016)

Table United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Inhalers for Chronic Obstructive Pulmonary Disorder Sales Share by Manufacturers

Figure 2016 Inhalers for Chronic Obstructive Pulmonary Disorder Sales Share by Manufacturers

Table United States Inhalers for Chronic Obstructive Pulmonary Disorder Revenue by Manufacturers (2015 and 2016)

Table United States Inhalers for Chronic Obstructive Pulmonary Disorder Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Inhalers for Chronic Obstructive Pulmonary Disorder Revenue Share by Manufacturers

Table 2016 United States Inhalers for Chronic Obstructive Pulmonary Disorder Revenue Share by Manufacturers

Table United States Market Inhalers for Chronic Obstructive Pulmonary Disorder Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Inhalers for Chronic Obstructive Pulmonary Disorder Average Price of Key Manufacturers in 2015

Figure Inhalers for Chronic Obstructive Pulmonary Disorder Market Share of Top 3 Manufacturers

Figure Inhalers for Chronic Obstructive Pulmonary Disorder Market Share of Top 5 Manufacturers

Table United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales by States (2012-2017)

Table United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales Share by States (2012-2017)

Figure United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales Market Share by States in 2015

Table United States Inhalers for Chronic Obstructive Pulmonary Disorder Revenue and Market Share by States (2012-2017)

Table United States Inhalers for Chronic Obstructive Pulmonary Disorder Revenue Share by States (2012-2017)

Figure Revenue Market Share of Inhalers for Chronic Obstructive Pulmonary Disorder by States (2012-2017)

Table United States Inhalers for Chronic Obstructive Pulmonary Disorder Price by States (2012-2017)

Table United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales by Type (2012-2017)

Table United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales Share by Type (2012-2017)

Figure United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales Market Share by Type in 2015

Table United States Inhalers for Chronic Obstructive Pulmonary Disorder Revenue and Market Share by Type (2012-2017)

Table United States Inhalers for Chronic Obstructive Pulmonary Disorder Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Inhalers for Chronic Obstructive Pulmonary Disorder by Type (2012-2017)

Table United States Inhalers for Chronic Obstructive Pulmonary Disorder Price by Type (2012-2017)

Figure United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales Growth Rate by Type (2012-2017)

Table United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales by Application (2012-2017)

Table United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales Market Share by Application (2012-2017)

Figure United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales Market Share by Application in 2015

Table United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales Growth Rate by Application (2012-2017)

Figure United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales Growth Rate by Application (2012-2017)

Table AstraZeneca Basic Information List

Table AstraZeneca Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)

Figure AstraZeneca Inhalers for Chronic Obstructive Pulmonary Disorder Sales Market Share (2012-2017)

Table Boehringer Ingelheim Basic Information List

Table Boehringer Ingelheim Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)

Table Boehringer Ingelheim Inhalers for Chronic Obstructive Pulmonary Disorder Sales Market Share (2012-2017)

Table GSK Basic Information List

Table GSK Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)

Table GSK Inhalers for Chronic Obstructive Pulmonary Disorder Sales Market Share (2012-2017)

Table Novartis Basic Information List

Table Novartis Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)

Table Novartis Inhalers for Chronic Obstructive Pulmonary Disorder Sales Market Share (2012-2017)

Table Teva Pharmaceuticals Basic Information List

Table Teva Pharmaceuticals Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)

Table Teva Pharmaceuticals Inhalers for Chronic Obstructive Pulmonary Disorder Sales Market Share (2012-2017)

Table Ache Laboratorios Farmaceuticos Basic Information List

Table Ache Laboratorios Farmaceuticos Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)

Table Ache Laboratorios Farmaceuticos Inhalers for Chronic Obstructive Pulmonary Disorder Sales Market Share (2012-2017)

Table Almirall Basic Information List

Table Almirall Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)

Table Almirall Inhalers for Chronic Obstructive Pulmonary Disorder Sales Market Share (2012-2017)

Table Aquinox Pharmaceuticals Basic Information List

Table Aquinox Pharmaceuticals Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)

Table Aquinox Pharmaceuticals Inhalers for Chronic Obstructive Pulmonary Disorder Sales Market Share (2012-2017)

Table Ario Pharma Basic Information List

Table Ario Pharma Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)

Table Ario Pharma Inhalers for Chronic Obstructive Pulmonary Disorder Sales Market Share (2012-2017)

Table Asmacure Basic Information List

Table Asmacure Inhalers for Chronic Obstructive Pulmonary Disorder Sales, Revenue, Price and Gross Margin (2012-2017)

Table Asmacure Inhalers for Chronic Obstructive Pulmonary Disorder Sales Market Share (2012-2017)

Table Astellas Pharma Basic Information List

Table BioMarck Pharmaceuticals Basic Information List

Table Others Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Inhalers for Chronic Obstructive Pulmonary Disorder

Figure Manufacturing Process Analysis of Inhalers for Chronic Obstructive Pulmonary Disorder

Figure Inhalers for Chronic Obstructive Pulmonary Disorder Industrial Chain Analysis

Table Raw Materials Sources of Inhalers for Chronic Obstructive Pulmonary Disorder Major Manufacturers in 2015

Table Major Buyers of Inhalers for Chronic Obstructive Pulmonary Disorder

Table Distributors/Traders List

Figure United States Inhalers for Chronic Obstructive Pulmonary Disorder Production and Growth Rate Forecast (2017-2022)

Figure United States Inhalers for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate Forecast (2017-2022)

Table United States Inhalers for Chronic Obstructive Pulmonary Disorder Production Forecast by Type (2017-2022)

Table United States Inhalers for Chronic Obstructive Pulmonary Disorder Consumption Forecast by Application (2017-2022)

Table United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales Forecast by States (2017-2022)

Table United States Inhalers for Chronic Obstructive Pulmonary Disorder Sales Share Forecast by States (2017-2022)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370